User profiles for Andrew Loblaw
 | LoblawSunnybrook Health Sciences Centre Verified email at sunnybrook.ca Cited by 18776 |
Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
Purpose Active surveillance is increasingly accepted as a treatment option for favorable-risk
prostate cancer. Long-term follow-up has been lacking. In this study, we report the long-term …
prostate cancer. Long-term follow-up has been lacking. In this study, we report the long-term …
Exercise for people with cancer: a systematic review
R Segal, C Zwaal, E Green, JR Tomasone, A Loblaw…�- Current�…, 2017 - mdpi.com
Background: This systematic review was completed by the Exercise for People with Cancer
Guideline Development Group, a group organized by Cancer Care Ontario’s Program in …
Guideline Development Group, a group organized by Cancer Care Ontario’s Program in …
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
…, A Lam, R Nam, A Mamedov, A Loblaw�- Journal of Clinical�…, 2010 - ascopubs.org
Purpose We assessed the outcome of a watchful-waiting protocol with selective delayed
intervention by using clinical prostate-specific antigen (PSA), or histologic progression as …
intervention by using clinical prostate-specific antigen (PSA), or histologic progression as …
[HTML][HTML] “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now
In 1847, 20 years before germ theory was popularised by Louis Pasteur, the Hungarian
physician Ignaz Semmelweis famously reduced maternal mortality from post-partum sepsis from …
physician Ignaz Semmelweis famously reduced maternal mortality from post-partum sepsis from …
Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes
A Loblaw, P Cheung, L D'Alimonte, A Deabreu…�- Radiotherapy and�…, 2013 - Elsevier
BACKGROUND AND PURPOSE: Biological dose escalation through stereotactic ablative
radiotherapy (SABR) holds promise of improved patient convenience, system capacity and …
radiotherapy (SABR) holds promise of improved patient convenience, system capacity and …
[HTML][HTML] Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international�…
…, AC Tree, P Ostler, H van der Voet, A Loblaw…�- The Lancet�…, 2019 - thelancet.com
Background Localised prostate cancer is commonly treated with external-beam radiotherapy.
Moderate hypofractionation has been shown to be non-inferior to conventional fractionation…
Moderate hypofractionation has been shown to be non-inferior to conventional fractionation…
[HTML][HTML] Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised�…
…, P Ostler, H van der Voet, W Chu, A Loblaw…�- The Lancet�…, 2022 - thelancet.com
Background Localised prostate cancer is commonly treated with external beam radiotherapy
and moderate hypofractionation is non-inferior to longer schedules. Stereotactic body …
and moderate hypofractionation is non-inferior to longer schedules. Stereotactic body …
Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2007 update of an American Society of Clinical Oncology�…
Purpose To update the 2004 American Society of Clinical Oncology (ASCO) guideline on
initial hormonal management of androgen-sensitive, metastatic, recurrent, or progressive …
initial hormonal management of androgen-sensitive, metastatic, recurrent, or progressive …
Active surveillance for intermediate risk prostate cancer: survival outcomes in the Sunnybrook experience
Purpose : To assess the applicability of active surveillance in patients with intermediate risk
prostate cancer, we compared the survival outcomes of patients with low risk and …
prostate cancer, we compared the survival outcomes of patients with low risk and …
Exercise for people with cancer: a clinical practice guideline
R Segal, C Zwaal, E Green, JR Tomasone, A Loblaw…�- Current�…, 2017 - mdpi.com
Background: Development of this guideline was undertaken by the Exercise for People with
Cancer Guideline Development Group, a group organized by Cancer Care Ontario’s …
Cancer Guideline Development Group, a group organized by Cancer Care Ontario’s …